Hepatitis E virus (HEV) genotypes 3 and 4 (HEV-3, HEV-4) infections are an emerging
public health issue in industrialized countries. HEV-3 and− 4 are usually self-limiting but can …

The pathogenic mechanisms determining the diverse clinical outcomes of HEV infection (eg,
self-limiting versus chronic or symptomatic versus asymptomatic) are not yet understood …

Abstract MicroRNAs (miRNAs), the non‐coding RNAs of~ 22 nucleotides (nt) in length, play
a vital role in regulating viral replication. Hepatitis E virus (HEV), a single‐stranded RNA …

The molecular mechanisms of liver pathology and clinical disease in hepatitis E virus (HEV)
infection remain unclear. MicroRNAs (miRNAs) are known to modulate viral pathogenesis …

The molecular mechanism of hepatitis E virus (HEV) pathology is still unclear. The micro
RNAs (miRNAs), of host or viral origin, interfere with virus replication and host environment …

Background Hepatitis E virus (HEV) causes about 14 million infections with 300,000 deaths
and 5,200 stillbirths worldwide annually. Extrahepatic manifestations are reported with HEV …

Abstract microRNAs (miRNAs) are small, noncoding RNAs which regulate eukaryotic gene
expression via RNA interference pathway. Recently, miRNAs have been identified in a …

Hepatitis E virus (HEV) has emerged as an important cause of epidemic and sporadic acute
viral hepatitis worldwide, which is a major public health challenge. A better understanding of …

The outcomes of hepatitis E virus (HEV) infection are diverse, ranging from asymptomatic
carrier, self‐limiting acute infection, and fulminant hepatitis to persistent infection. This is …

Abstract Background. Hepatitis E virus (HEV) genotype 3 infections are frequent in Europe
and North America, with acute and chronic courses described in the literature. HEV RNA …